If you would like to ask our webinar guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund a question please submit them here.

 

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Issue of share options

31 Jan 2022 15:54

RNS Number : 2005A
Applied Graphene Materials PLC
31 January 2022
 

 

 

31 January 2022

Issue of share options

Applied Graphene Materials (LSE: AGM), the producer of specialty graphene materials and dispersions, announces that share options over ordinary shares of 2 pence each in the Company have today been granted to certain employees under the terms of the Company's Save As You Earn Share Plan.

 

A total of 561,972 share options have been granted, including 52,325 to Adrian Potts, CEO of the Company and PDMR, as disclosed below:

 

Name

Position

Number of shares subject to Option

Option exercise price per share

Total number of options held under all schemes

Adrian Potts

CEO & PDMR

52,325

£0.172

832,093

 

The option exercise price was set on 12 January 2022, being the day prior to invitation to join the Save As You Earn Share Plan. No performance conditions attach to these options, which may be exercised in the six month period from 1 February 2025 to 31 July 2025. Nil consideration is payable in respect of the grant of options.

For further information, please contact:

 

Applied Graphene Materials +44 (0) 1642 438 214

Adrian Potts, Chief Executive Officer

David Blain, Chief Financial Officer

 

Singer Capital Markets +44 (0) 207 496 3000

Peter Steel / Amanda Gray

 

Allenby Capital Limited +44 (0) 203 328 5656

Nick Athanas / Liz Kirchner (Corporate Finance)

Matt Butlin / Kelly Gardiner (Sales and Corporate Broking)

 

Hudson Sandler +44 (0) 207 796 4133

Nick Lyon / Emily Dillon

 

Notes to Editors

 

Applied Graphene Materials - For the last decade, AGM has been at the forefront of harnessing the possibilities of graphene. Founded originally by Professor Karl Coleman, the Group has grown from an academic idea from Durham University to a world leader in the development and application of graphene nanoplatelet dispersions for customers in the coatings, composites and functional materials sectors.

 

The Group utilises its proprietary bottom-up manufacturing process to produce high purity graphene nanoplatelets. Its expertise in dispersion chemistry enables AGM to create optimised, stable and easy to handle dispersions that customers use in real-world industrial products. AGM's unique approach enables industries to fully realise the potential of graphene in a simple, safe and easy to formulate way. 

 

AGM, based at the Wilton Centre on Teesside, was admitted to AIM in November 2013, raising £11 million. The Group successfully raised £8.5m in January 2016, £9.8m in November 2017 and a further £6m gross in January 2021. The Group's shares are also cross-traded on OTCQX in the United States. As a result of the funding support and its industry leading technology platform, AGM has been able to develop a significant sales distribution network covering Europe, North America and Asia. The Group continues to work closely with industrial partners, and has seen the successful launch of numerous commercial products enhanced by its Graphene Dispersions.

https://www.appliedgraphenematerials.com/

 

The information set out below is provided in accordance with the requirements of Article 19(3) of the EU Market Abuse Regulation No 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Adrian Potts

2

Reason for the notification

a)

Position/status

Chief Executive Officer (PDMR)

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Applied Graphene Materials plc

b)

LEI

213800OA661EWZOW5253

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

 

Identification code

 

Options over ordinary shares of 2 pence each

 

 

GB00BFSSB742

b)

Nature of the transaction

Grant of Options

c)

 

Price(s) and volume(s)

 

Price

Volume

N/A

52,325

d)

Aggregated information

- Aggregated volume

- Price

 

 

n/a - single transaction

 

e)

Date of the transaction

31 January 2022

f)

Place of the transaction

Outside a trading venue

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHWPUGAGUPPGAG
Date   Source Headline
25th Apr 20187:00 amRNSIssue of share options to Directors
18th Apr 20188:41 amRNSHolding(s) in Company
10th Apr 20187:00 amRNSInterim Results
8th Mar 20187:00 amRNSCollaboration with SHD and Magna Exteriors
1st Feb 20187:00 amRNSBoard Change
15th Jan 20189:22 amRNSHolding(s) in Company
10th Jan 20185:30 pmRNSHolding(s) in Company
10th Jan 20184:40 pmRNSSecond Price Monitoring Extn
10th Jan 20184:35 pmRNSPrice Monitoring Extension
8th Jan 20181:21 pmRNSHolding(s) in Company
4th Jan 20187:00 amRNSResult of AGM
3rd Jan 20187:00 amRNSAGM Statement
12th Dec 20177:00 amRNSNotice of AGM
7th Nov 20179:47 amRNSHolding(s) in Company
2nd Nov 20177:00 amRNSDirector/PDMR Shareholding
30th Oct 20171:15 pmRNSResults of Open Offer and General Meeting
12th Oct 20175:19 pmRNSPosting of Circular and Notice of General Meeting
10th Oct 20176:16 pmRNSFurther Details on the Fundraising
10th Oct 201711:41 amRNSClose of Accelerated Bookbuild
10th Oct 201711:00 amRNSPrice Monitoring Extension
10th Oct 20177:05 amRNSProposed Placing by Accelerated Bookbuild
10th Oct 20177:00 amRNSPreliminary Results
22nd Aug 20177:00 amRNSInvestor Site Visit
24th May 20177:00 amRNSNew Graphene Delivery Technology & Trading Update
22nd May 20174:18 pmRNSIssue of Equity and Total Voting Rights
26th Apr 20174:35 pmRNSPrice Monitoring Extension
11th Apr 20177:00 amRNSInterim Results
7th Apr 20174:40 pmRNSSecond Price Monitoring Extn
7th Apr 20174:35 pmRNSPrice Monitoring Extension
5th Apr 20174:40 pmRNSSecond Price Monitoring Extn
5th Apr 20174:35 pmRNSPrice Monitoring Extension
1st Feb 20177:00 amRNSGrant of Options
30th Jan 20177:00 amRNSShare Purchase by CFO-Designate
25th Jan 20177:00 amRNSBoard & Operational Appointments
20th Dec 20167:00 amRNSAGM Statement
31st Oct 20167:01 amRNSDirector/PDMR Shareholding
31st Oct 20167:00 amRNSDirectorate Change
17th Oct 20167:00 amRNSFinal Results
14th Oct 20167:00 amRNSFirst Production Order
12th Aug 20167:38 amRNSExercise of Share Options and PDMR Dealing
12th Aug 20167:00 amRNSDirectorate Change
12th Aug 20167:00 amRNSPeriod end trading update and notice of results
8th Aug 20167:00 amRNSProduct Development and New JDA
23rd Mar 20167:00 amRNSInterim Results
26th Jan 20163:21 pmRNSHolding(s) in Company
26th Jan 201612:15 pmRNSResult of AGM
25th Jan 20167:00 amRNSAGM Statement
22nd Jan 201610:33 amRNSHolding(s) in Company
13th Jan 20169:08 amRNSHolding(s) in Company
11th Jan 20163:42 pmRNSIssue of share options to Directors

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.